Analysts Expect Corbus Pharmaceuticals (CRBP) Stock to Gain 241%; Rated Strong Buy

 

Corbus Pharmaceuticals Holdings Inc (CRBP) stock has risen 14.17% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives CRBP stock an overall score of 74 out of a possible 100.

That score is mainly influenced by a long-term technical score of 89. CRBP’s score also includes a fundamental score of 84. In addition to the average rating from Wall Street analysts, CRBP stock has a mean target price of $24.75. This means analysts expect the stock to add 241.38% over the next 12 months. The short-term technical score for CRBP is 48.

Click Here to get the full Stock Score Report on Corbus Pharmaceuticals Holdings Inc (CRBP).

What’s Happening with CRBP Stock Today

Corbus Pharmaceuticals Holdings Inc (CRBP) stock is down -2.77% while the S&P 500 is lower by -2.05% as of 3:22 PM on Tuesday, May 7. CRBP is lower by -$0.21 from the previous closing price of $7.46 on volume of 455,162 shares. Over the past year the S&P 500 has risen 7.48% while CRBP has risen 14.17%. CRBP lost -$0.98 per share in the over the last 12 months.

Symbols: CRBP

You May Also Like